These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 26087255

  • 1. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.
    Traitanon O, Mathew JM, La Monica G, Xu L, Mas V, Gallon L.
    PLoS One; 2015; 10(6):e0129658. PubMed ID: 26087255
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
    Gallon L, Traitanon O, Yu Y, Shi B, Leventhal JR, Miller J, Mas V, L X, Mathew JM.
    Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S, Sarafnejad A, Ahmadpoor P, Nafar M, Karimi M, Eteghadi A, Yekaninejad MS, Amirzargar AA.
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O, Jiménez O, Fortuna V, Barceló JJ, Brunet M.
    Int J Immunopathol Pharmacol; 2006 Sep; 19(2):317-30. PubMed ID: 16831299
    [Abstract] [Full Text] [Related]

  • 8. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.
    Heidt S, Roelen DL, Eijsink C, van Kooten C, Claas FH, Mulder A.
    Transplantation; 2008 Nov 15; 86(9):1292-300. PubMed ID: 19005412
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients.
    Li Y, Shi Y, Liao Y, Yan L, Zhang Q, Wang L.
    Int Immunopharmacol; 2015 Sep 15; 28(1):435-43. PubMed ID: 26186486
    [Abstract] [Full Text] [Related]

  • 10. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
    Chu ZQ, Ji Q.
    Transplant Proc; 2013 Sep 15; 45(1):153-6. PubMed ID: 23375290
    [Abstract] [Full Text] [Related]

  • 11. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.
    Merino D, San Segundo D, Medina JM, Rodrigo E, Asensio E, Irure J, Fernández-Fresnedo G, Arias MA, López-Hoyos M.
    Immunology; 2016 Jun 15; 148(2):206-15. PubMed ID: 26931075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.
    Morelon E, Lefrançois N, Besson C, Prévautel J, Brunet M, Touraine JL, Badet L, Touraine-Moulin F, Thaunat O, Malcus C.
    Transpl Immunol; 2010 May 15; 23(1-2):53-8. PubMed ID: 20406686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses.
    Levitsky J, Miller J, Huang X, Gallon L, Leventhal JR, Mathew JM.
    PLoS One; 2016 May 15; 11(6):e0156535. PubMed ID: 27275747
    [Abstract] [Full Text] [Related]

  • 17. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.
    Kim KW, Chung BH, Kim BM, Cho ML, Yang CW.
    Immunology; 2015 Jan 15; 144(1):68-78. PubMed ID: 24974886
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
    Liang H, Liao C, Qi Z, Sha C, Xie B, Chen J, Xia J, Wang Y, Yao Q, Zhao Y.
    Transpl Immunol; 2010 Feb 15; 22(3-4):128-36. PubMed ID: 19755159
    [Abstract] [Full Text] [Related]

  • 19. Pseurotin D Inhibits the Activation of Human Lymphocytes.
    Rubanova D, Dadova P, Vasicek O, Kubala L.
    Int J Mol Sci; 2021 Feb 16; 22(4):. PubMed ID: 33669259
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Transplantation; 2004 Apr 27; 77(8):1154-62. PubMed ID: 15114077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.